ArticleFrontiers in immunology2025
Evolving fitness and immune escape: a retrospective analysis of SARS-CoV-2 spike protein (2020-2024) using protein language model.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The COVID-19 pandemic posed global health challenges. Understanding SARS-CoV-2's evolutionary dynamics, especially fitness and immune escape, is vital for public health. This study uses protein language models to assess how genetic variations affect viral adaptability and immunity. Methods: We applied the CoVFit model to predict Fitness and Immune Escape Index (IEI), validated by a null model based on neutral evolution. We analyzed 2,504,278 SARS-CoV-2 spike sequences, including 160,892 variants, tracking evolution from 2020 to May 2024, comparing real and random mutants' Fitness and IEI. Results: Our analysis revealed an increase in Fitness (mean rising from 0.227 in 2020 to 0.930 in 2024) and IEI (mean increasing from 0.171 to 0.555) for North American samples. Globally, the comparison of Fitness and IEI between real and random mutants (generated by the null model) revealed statistically significant differences (real mutant Fitness 0.3849 vs. random mutant 0.2046, p < 0.001, KS test; real mutant IEI 0.2894 vs. random mutant 0.1895, p < 0.001, KS test), indicating strong selective pressure; the JN.1 lineage dominated (94% of sequences by April 2024), underscoring its evolutionary advantage. Conclusions: CoVFit offers key insights into SARS-CoV-2 evolution, aiding vaccine design. Persistent viral adaptation despite interventions highlights the need for surveillance and adaptive strategies using tools like CoVFit for preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.